Blog

The Parallel Roads of Representation and Access

October 28, 2021

Guest post by: Dana Dornsife, Founder and CEO, Lazarex Cancer Foundation There are many avenues to addressing health disparities, an essential health policy objective. To determine the most appropriate strategies, … Continued

Understanding State Laws for Interchangeable Biosimilars

October 15, 2021

An important development in the biopharmaceutical world, with significant ramifications for patients, is the progress being made on biosimilars. These are products with the same safety and efficacy as FDA-approved … Continued

Lawmakers Have a Drug Pricing Solution Right in Front of Them

October 4, 2021

As Congress continues to deliberate on drug pricing proposals that many would call extreme, even radical – empowering the federal government to set prices instead of having prices negotiated in … Continued